TcMedicine
Medicine and Health
New Study Re-evaluates Cardiovascular Risks Of Non-steroidal Anti-inflammatory Drugs (NSAIDS)
Saturday, September 27th, 2008Pain / Anesthetics NewsUseful LinksVideo Library
New Study Re-evaluates Cardiovascular Risks Of Non-steroidal Anti-inflammatory Drugs (NSAIDS)
Main Category: Pain / Anesthetics News
Article Date: 02 Jun 2006 - 5:00 PDT
email to a friend printer friendly
New Understanding Of COX-1 And COX-2 Enzymes Could Revise Classification Of Pain Meds
Saturday, September 27th, 2008Pain / Anesthetics NewsUseful LinksVideo Library
New Understanding Of COX-1 And COX-2 Enzymes Could Revise Classification Of Pain Meds
Main Category: Pain / Anesthetics News
Article Date: 30 May 2006 - 0:00 PDT
email to a friend printer friendly view
Music Eases Perception Of Chronic Pain
Saturday, September 27th, 2008Pain / Anesthetics NewsUseful LinksVideo Library
Music Eases Perception Of Chronic Pain
Featured Article
Main Category: Pain / Anesthetics News
Article Date: 29 May 2006 - 9:00 PDT
email to a friend printer friendly view / write opinions
Establishing Trust Between Physicians And Patients With Rheumatic Diseases - Relationships Can Be Improved By Using Patient-centered Approach
Saturday, September 27th, 2008Arthritis NewsUseful Links
Establishing Trust Between Physicians And Patients With Rheumatic Diseases - Relationships Can Be Improved By Using Patient-centered Approach
Main Category: Arthritis News
Article Date: 29 May 2006 - 4:00 PDT
email to a friend
Roche Comment On NICE Anti-TNF Inhibitor Sequencing FAD
Saturday, September 27th, 2008Following the widespread media coverage regarding the NICE FAD on the sequencingof anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis andrheumatology health professionals that they will continue to benefit from access toeffective treatment with MabThera
New Survey Findings Reveal Emotional And Physical Toll Of Rheumatoid Arthritis And The Advancement Of Treatment Through
Saturday, September 27th, 2008Emotional and physical limitations are significant challenges cited by people diagnosed with rheumatoid arthritis (RA), according to the results released from two new, groundbreaking parallel surveys. According to the GeneRAtions™ surveys one of which includes feedback from more
Who Cares Wins: Medical Journalists Vote Arthritis Care Health Charity Of The Year, UK
Saturday, September 27th, 2008The UK’s leading organisation supporting and representing the interests of people with any of the 200 forms of arthritis was last night voted Health Charity of the Year by members of the Medical Journalists’ Association.
The user-led charity, which celebrated its
Cimzia(R) Filed With EMEA For Treatment Of Rheumatoid Arthritis, Europe
Saturday, September 27th, 2008UCB announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMEA) requesting the approval of Cimzia® (certolizumab pegol) as a subcutaneous treatment for adults with moderate to severe active rheumatoid arthritis (RA) and has
Joint Damage Is Inhibited With Enbrel
Saturday, September 27th, 2008Data presented recently show that 80% of patients with early active rheumatoid arthritis achieved radiographic remission (or non-progression defined as a change in TSS≤0.5) at one year when treated with Enbrel (etanercept) and methotrexate, compared to 59% when treated with
Actemra Is First Biologic Agent To Show Better Efficacy Than Methotrexate In RA
Saturday, September 27th, 2008PARIS: The interleukin-6 receptor inhibitor Actemra (tocilizumab) achieves significantly greater reduction in the signs and symptoms of rheumatoid arthritis (RA) than the current standard of care, methotrexate, according to two international clinical trials reported this week at EULAR
